Connor, Clark & Lunn Investment Management (CC&L)’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
|
|||||
|
2025
Q1 | $2.46M | Buy |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $940K | Buy |
|
|||||
|
2024
Q2 | $1.16M | Sell |
|
|||||
|
2024
Q1 | $2.05M | Buy |
|
|||||
|
2023
Q4 | $852K | Sell |
|
|||||
|
2023
Q3 | $525K | Hold |
|
|||||
|
2023
Q2 | $705K | Buy |
|
|||||
|
2023
Q1 | $568K | Buy |
|
|||||
|
2022
Q4 | $775K | Buy |
|
|||||
|
2022
Q3 | $354K | Buy |
|
|||||
|
2022
Q2 | $221K | Sell |
|
|||||
|
2022
Q1 | $261K | Sell |
|
|||||
|
2021
Q4 | $305K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $97K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $263K | Sell |
|
|||||
|
2016
Q2 | $796K | Sell |
|
|||||
|
2016
Q1 | $800K | Sell |
|
|||||
|
2015
Q4 | $2.3M | Sell |
|
|||||
|
2015
Q3 | $2.7M | Buy |
|
|||||
|
2015
Q2 | $4.16M | Buy |
|
|||||
|
2015
Q1 | $8.26M | Buy |
|
|||||
|
2014
Q4 | $3.96M | Buy |
|
|||||
|
2014
Q3 | $2.05M | Buy |
|